The French biotech firm Valneva says that early studies show its coronavirus vaccine is effective against Omicron and it might be able to deliver doses to the European public in April. Officials from Valneva released a statement to the public on Wednesday that indicated its preliminary studies showed that three doses of its inactivated coronavirus vaccine […] Read the full story on GreekReporter.com.
 |
| READ THE ORIGINAL POST AT greekreporter.com |
